REUTERS/2TangoMedicins Sans Frontieres (MSF) health workers prepare at ELWA's isolation camp during the visit of Senior United Nations (U.N.) System Coordinator for Ebola David Nabarro, at the camp in Monrovia August 23, 2014.
Shares of Tekmira Pharmaceuticals, which have been rallying on hopes for broad use of the company's Ebola treatment, are taking a beating on Monday.
Also read: Caterpillar Says Sales Woes Could Linger
20:52 After earning crush, Tesla expected to unveil 'solar roof', integrated home battery29
12:23 Lockheed Martin's quarterly profit handily beats estimates19
11:41 Caterpillar earnings: 85 cents per share, vs expected EPS of 76 cents18
21:31 Time Warner jumps after hours on report it could sell for $110 per share to AT&T6